Franco Locatelli Selected Research

Leukemia

1/2024	Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study.
12/2023	The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.
12/2023	CD72 is a pan-tumor antigen associated to pediatric acute leukemia.
11/2023	Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion.
9/2023	TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.
1/2023	Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
1/2022	Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation.
1/2022	Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.
11/2021	The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics.
8/2021	The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franco Locatelli Research Topics

Disease

143	Neoplasms (Cancer) 05/2024 - 05/2002
82	Leukemia 01/2024 - 10/2002
80	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 07/2002
56	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023 - 05/2002
40	Infections 01/2024 - 12/2002
34	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 05/2002
27	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 02/2003
23	Neuroblastoma 03/2024 - 03/2011
22	COVID-19 01/2023 - 01/2020
18	Thalassemia 12/2023 - 06/2002
17	Residual Neoplasm 12/2023 - 08/2005
17	beta-Thalassemia (Cooley's Anemia) 01/2023 - 06/2002
13	Bronchiolitis Obliterans Syndrome 07/2023 - 08/2002
12	Aplastic Anemia (Anemia, Hypoplastic) 04/2024 - 09/2004
12	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2023 - 06/2005
12	Juvenile Myelomonocytic Leukemia 01/2021 - 04/2004
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 06/2002
10	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2024 - 04/2012
10	Disease Progression 11/2023 - 05/2002
9	Cytomegalovirus Infections (Inclusion Disease) 01/2024 - 04/2005
9	Lymphoma (Lymphomas) 12/2023 - 09/2004
9	Glioma (Gliomas) 09/2023 - 01/2005
9	Inflammation (Inflammations) 05/2023 - 06/2007
9	Acute Promyelocytic Leukemia 01/2023 - 01/2004
8	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 06/2006
8	Sickle Cell Anemia (Hemoglobin S Disease) 10/2023 - 03/2003
8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 04/2003
7	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 01/2015
7	Medulloblastoma 01/2023 - 01/2016
7	Cytokine Release Syndrome 01/2023 - 01/2019
7	Fanconi Anemia (Fanconi's Anemia) 01/2021 - 09/2007
7	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2019 - 04/2002
6	Brain Neoplasms (Brain Tumor) 04/2024 - 07/2013
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2023 - 08/2003
6	Rhabdomyosarcoma 01/2023 - 09/2011
6	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2016
5	Carcinogenesis 04/2024 - 05/2012
5	Hemorrhage 01/2023 - 07/2005
5	Bone Marrow Failure Disorders 11/2022 - 09/2007
5	Diffuse Intrinsic Pontine Glioma 01/2022 - 05/2017
5	Neutropenia 07/2019 - 12/2002
4	Communicable Diseases (Infectious Diseases) 01/2024 - 02/2012
4	Hematologic Diseases (Blood Diseases) 12/2023 - 07/2008
4	Cytopenia 11/2023 - 04/2014
4	Lymphopenia (Lymphocytopenia) 01/2023 - 01/2019
4	Philadelphia Chromosome 01/2023 - 02/2010
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2009

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 11/2022 - 08/2005
20	blinatumomabIBA 05/2023 - 12/2016
20	LigandsIBA 01/2023 - 08/2003
17	AntigensIBA 12/2023 - 02/2000
16	CytokinesIBA 05/2023 - 06/2007
15	Chimeric Antigen ReceptorsIBA 11/2023 - 12/2013
15	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2005
13	fludarabineIBA 10/2023 - 11/2002
12	SteroidsIBA 07/2023 - 01/2007
12	AntibodiesIBA 01/2023 - 07/2009
12	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2011
10	Monoclonal AntibodiesIBA 01/2021 - 02/2002
9	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 05/2002
9	treosulfanIBA 01/2024 - 07/2012
9	Messenger RNA (mRNA)IBA 11/2023 - 06/2003
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 01/2006
9	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 04/2002
9	EnzymesIBA 05/2023 - 02/2012
9	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 08/2008
8	VaccinesIBA 11/2022 - 10/2013
7	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2024 - 08/2003
7	Busulfan (Busulfex)FDA Link 01/2024 - 02/2014
7	Antiviral Agents (Antivirals)IBA 01/2021 - 06/2003
7	KIR ReceptorsIBA 01/2016 - 03/2009
6	Neoplasm Antigens (Tumor Antigens)IBA 12/2023 - 05/2004
6	ruxolitinibIBA 07/2023 - 09/2016
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023 - 01/2004
6	Immunoglobulins (Immunoglobulin)IBA 05/2022 - 04/2008
6	Inosine Triphosphate (ITP)IBA 01/2022 - 04/2003
6	InterferonsIBA 01/2021 - 10/2004
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 06/2002
6	Rituximab (Mabthera)FDA Link 01/2020 - 02/2002
6	Prednisone (Sone)FDA LinkGeneric 02/2016 - 07/2002
5	Inotuzumab OzogamicinIBA 01/2024 - 01/2021
5	EmapalumabIBA 11/2023 - 11/2019
5	Etoposide (VP 16)FDA LinkGeneric 11/2022 - 03/2011
5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2022 - 01/2016
5	dipinacoline glutamateIBA 01/2022 - 05/2017
5	immune RNA (I-RNA)IBA 01/2022 - 02/2012
5	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 03/2006
4	Azacitidine (5 Azacytidine)FDA Link 03/2024 - 02/2015

Therapy/Procedure

131	Therapeutics 05/2024 - 04/2002
129	Hematopoietic Stem Cell Transplantation 03/2024 - 05/2002
80	Transplantation 10/2023 - 05/2002
49	Drug Therapy (Chemotherapy) 05/2024 - 10/2002
40	Stem Cell Transplantation 10/2023 - 05/2002
30	Immunotherapy 10/2023 - 03/2011
15	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2013 - 06/2002
6	Cell Transplantation 01/2020 - 03/2009
5	Combined Modality Therapy 03/2024 - 01/2020
5	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 12/2005
4	Haploidentical Transplantation 09/2023 - 10/2014
4	Splenectomy 11/2022 - 10/2013